ProfileGDS4132 / 205832_at
TitlePPAR-γ agonist pioglitazone effect on obese women with polycystic ovary syndrome: skeletal muscle
OrganismHomo sapiens


pretreatment pioglitazone GSM201542 GSM201543 GSM201544 GSM201545 GSM201829 GSM201830 GSM201831 GSM201832 GSM201833 GSM201834 GSM201835 GSM201836 GSM201837 GSM201838 GSM201839 GSM201840 GSM201841 GSM201842 GSM201843 GSM201844 80% 79% 74% 83% 79% 79% 79% 68% 78% 81% 83% 81% 78% 74% 87% 84% 85% 83% 82% 85% sort by agent Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM201542Muscle PCOS pioglitazone 101269.11980
GSM201543Muscle PCOS pioglitazone 121248.95479
GSM201544Muscle PCOS pioglitazone 161242.16274
GSM201545Muscle PCOS pioglitazone 201324.88283
GSM201829Muscle PCOS pioglitazone 231278.43979
GSM201830Muscle PCOS pioglitazon 251269.40279
GSM201831Muscle PCOS pioglitazone 271272.39779
GSM201832Muscle PCOS pioglitazone 31193.53468
GSM201833Muscle PCOS pioglitazone 41248.73878
GSM201834Muscle PCOS pioglitazone 81294.98481
GSM201835Muscle PCOS after pioglitazone 102308.75583
GSM201836Muscle PCOS after pioglitazone 122289.49981
GSM201837Muscle PCOS after pioglitazone 162244.08778
GSM201838Muscle PCOS after pioglitazone 202235.38474
GSM201839Muscle PCOS after pioglitazone 232376.13387
GSM201840Muscle PCOS after pioglitazone 252351.38884
GSM201841Muscle PCOS after pioglitazone 272326.13285
GSM201842Muscle PCOS after pioglitazone 32289.63283
GSM201843Muscle PCOS after pioglitazone 42299.20582
GSM201844Muscle PCOS after pioglitazone 82347.2485